White paper: Integrating pharmacogenomics into the standard of care

Pharmacogenomics (PGx) can lead to better overall quality of care by making sure that medications are prescribed with the specific individual in mind, rather than guessing what may work best under the “standard of care” paradigm.

PGx helps provide a better understanding of how variations in key areas of an individual's genome may impact the efficacy of a medication, dosage considerations, and potential adverse drug reactions (ADRs). Thus, PGx has become a vital piece of the overall healthcare puzzle.

Download the whitepaper “Integrating pharmacogenomics into the standard of care” to learn more about the implementation hurdles that need to be overcome, as well as PGx tools that are readily available now.



Would you like a quote on Thermo Fisher Scientific’s PGx products and solutions?

I would like to receive information about events, products, services and promotions from Thermo Fisher Scientific and its affiliates:

 

By following relevant data privacy laws, Thermo Fisher Scientific will take great care in processing my personal data in line with its privacy policy, which can be reviewed at thermofisher.com/privacypolicy.

I can choose to unsubscribe at any time by e-mailing reply@thermofisher.com